Eyeliss™ MBAL is a peptide complex combining three biomimetic peptides of cosmetic interest. Available scientific data associate it with visible reduction of under-eye bags and improvement in eye contour appearance.
Several independent clinical studies published in the Journal of Cosmetic Dermatology and the Journal of Drugs in Dermatology report documented results after twice-daily application for 56 days. On bag reduction: visible reduction of bag appearance was reported in 70% of participants using the ingredient, versus 30% with placebo. On dark circle reduction: improvement in dark circle appearance was reported in 35% of participants, versus 10% with placebo.
Beyond visible reduction of bags and dark circles, Eyeliss™ MBAL is also linked, according to available data, to overall improvement in skin appearance around the eyes and visible reduction of redness.
The reported results concern the ingredient alone and do not predict finished product results.
